Project Number 3R43AG076088-01S1 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Alzheimer's disease and novel nanotherapeutics exclusively targeting extrasynaptic NMDA receptors Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) d. Neurotransmitter Receptors Category F. Research Resources 3. Professional and Career Development b. Fellowships Researcher and Organization Principal Investigator MOLOKANOVA, ELENA Principal Investigator First Name ELENA Principal Investigator Last Name MOLOKANOVA Awardee Organization NEURANO BIOSCIENCE Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA-21-345: Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) FY Overall Cost $56,626 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
